Partners Yuki Onoe and Daniel J. Pereira, Ph.D., have been promoted to Co-heads of the Chemical Patent Prosecution Group.
Last month, the Federal Circuit affirmed the District Court of Delaware's decision in Persion Pharmaceuticals v. Alvogen invalidating as obvious two Persion patents claiming methods of treating pain in patients with hepatic impairment (compromised liver functionality) using hydrocodone. Important to the Federal Circuit's decision was the concept of "inherency."
Chico Gholz quoted in the article "Amgen Kidney Drug Ruling May Expand Patent Prosecution."
The Oblon and Maiwald firms are pleased to invite you to a complementary Joint International Symposium on U.S. and European Patent Practice that will be presented on February 20, 2020 at the Hotel Sofitel Munich Bayerpost.
Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.
Oblon's Patent Prosecution practice and partners from the firm's Chemical, Electrical & Mechanical and Litigation practices have received top national rankings in the 2019 edition of IAM Patent 1000: The World's Leading Patent Professionals.